Summary
Lisuride, an ergot D2 dopamine receptor agonist inhibited dopamine synthesis in striatal synaptosomes concentration-dependently. Significant inhibition was detected at 10−8 M, and the inhibition by 10−4 M lisuride was 50%. The inhibitory effect of lisuride was reversed by more than 50% not only by the D1-D2 dopamine receptor blocker haloperidol but also by the D2 dopamine receptor blocker (−)-sulpiride. The effect of sulpiride was stereospecific. Under the same test conditions a similar inhibition of dopamine synthesis by apomorphine was reversed by the neuroleptics almost completely. The results suggest that there are dopamine autoreceptors controlling dopamine synthesis in synaptosomes and these receptors resemble D2 dopamine receptors according to the nomenclature of Kebabian and Calne (1979).
This is a preview of subscription content, log in via an institution to check access.
References
Ålander T, Anden NE, Grabowska-Anden M (1980) Metoclopramide and sulpiride as selective blocking agents of pre-and postsynaptic dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 312:145–150
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney WE (eds) Pre-and postsynaptic receptors. Marcel Dekker, New York, pp 49–65
Cerrito F, Raiteri M (1980) Dopamine biosynthesis is regulated by the amine newly recaptured by dopaminergic nerve endings. Eur J Pharmacol 68:465–470
Christiansen J, Squires RF (1974) Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J Pharm Pharmacol 26:367–369
Ebstein B, Roberge C, Tabachnick J, Goldstein M (1974) The effect of dopamine and of apomorphine on dB-cAMP-induced stimulation of synaptosomal tyrosine hydroxylase. J Pharm Pharmacol 26:975–977
Goldstein M, Bronaugh RL, Ohashi T, Ebstein B (1977) In: Usdin E, Hamburg DA, Barchas JD (eds) Neuroregulators and psychiatric disorders. Oxford University Press, New York, pp 538–544
Iversen LL, Rogawski MA, Miller RJ (1975) Comparison of the effects of neuroleptic drugs on pre-and postsynaptic dopaminergic mechanisms in the rat striatum. Mol Pharmacol 12:251–262
Kebabian JW, Kebabian PR (1978) Lergotrile and lisuride: in vivo dopaminergic agonists which do not stimulate the presynaptic dopamine autoreceptor. Life Sci 23:2199–2204
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kehr W (1977) Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain. Eur J Pharmacol 41:261–273
Marek KL, Roth RH (1980) Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercels. Eur J Pharmacol 62:137–145
Raiteri M, Maura G (1981) Control of dopamine synthesis, 8th International Symposium of Pharmacology, Satellite Symposium on Dopamine. Okayama, Japan, Abstracts, p 51
Spano PF, Stefanini E, Trabucchi M, Fresia P (1979) Stereospecific interaction of sulpiride with striatal and nonstriatal deopamine receptors. In: Spano PF, Trabuchi M, Corsini GU, Gessa GL (eds) Sulpiride and other benzamides. Italian Brain Research Foundation Press, Milan, Italy, pp 11–31
Tissari AH, Gessa GL (1981) New evidence for dopamine receptors in synaptosomes controlling dopamine synthesis. In: Gessa GL, Corsini GU (eds) Apomorphine and other dopaminomimetics, vol 1. Basic pharmacology. Raven Press, New York, pp 105–116
Tissari AH, Stefanini E, Gessa GL (1979) Stimulation of dopamine synthesis and activation of tyrosine hydroxylase by (−)sulpiride, sultopride and tiapride. In: Spano PF, Trabucchi M, Corsini GU, Gessa GL (eds) Sulpiride and other benzamides. Italian Brain Research Foundation Press, Milan, pp 3–11
Waggoner WG, McDermed J, Leighton HJ (1980) Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs. Mol Pharmacol 18:91–99
Walters JR, Roth RH (1976) Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5–14
Walters JR, Baring MD, Lakoski JM (1978) Effect of dopamine agonists on dopaminergic units activity. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: Basic and clinical frontiers, vol 1, Pergamon Press, New York, pp 637–639
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tissari, A.H., Atzori, L. & Galdieri, M.T. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: Stereospecific reversal by (−)-sulpiride. Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 89–91 (1983). https://doi.org/10.1007/BF00649358
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00649358